Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1041, 2005-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bayer Healthcare issues important Trasylol safety info
Reactions Weekly, Vol. 1, Iss. 1091, 2006-01 ,pp. :
Access to resources
Recommend
Bayer issues new Trasylol safety info in Canada
Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. :
NSAIDs: "little evidence" to support cardiovascular safety
Reactions Weekly, Vol. 1, Iss. 1340, 2011-01 ,pp. :
Phase I results support ocular safety of mirabegron
Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. :
Postmarketing support for safety profile of DTaP vaccine
Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. :